WGS
GeneDx Holdings Corp.
GeneDx Holdings Corp. (WGS) has 21 SEC Form 4 filings (120 transaction rows) in the rolling window, disclosed by 6 distinct insiders. Most recent filing: Jun 23, 2026.
The most active filer is Director, 10% Owner Meister Keith A. with 6 filings. Insiders have net bought $75.6M over the trailing 6 months. The largest single insider purchase in this window was $20.2M by Director, 10% Owner Meister Keith A. on May 7, 2026.
- Industry:Medical - Healthcare Information Services
- CEO:Katherine A. Stueland
- Employees:1,000
- HQ:Stamford, CT, US
- IPO:2020-11-04
Insider Buying
$82.0M
reported purchases (SEC code P)
Insider Selling
$16.8M
reported sales (SEC code S)
Unique Insiders
6
in the rolling window
Market Cap
$1.9B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Feeley KevinFirst in 3 months | CHIEF FINANCIAL OFFICER | Sale | 3,729 | $227K | Jun 18 | SEC ↗ |
| CHIEF EXECUTIVE OFFICER | Sale | 10,501 | $638K | Jun 18 | SEC ↗ | |
Casdin Capital, LLCFirst filing | Director, 10% Owner | Purchase | 175,000 | $7.4M | May 20 | SEC ↗ |
Casdin Capital, LLCFirst filing | Director, 10% Owner | Purchase | 185,000 | $7.9M | May 20 | SEC ↗ |
Casdin Capital, LLCFirst filing | Director, 10% Owner | Purchase | 140,000 | $6.1M | May 20 | SEC ↗ |
| Director, 10% Owner | Purchase | 165,000 | $6.4M | May 15 | SEC ↗ | |
| Director, 10% Owner | Purchase | 140,000 | $5.5M | May 15 | SEC ↗ | |
| Director, 10% Owner | Purchase | 46,273 | $1.8M | May 15 | SEC ↗ | |
Meister Keith A.First filing | Director, 10% Owner | Purchase | 533,758 | $20.2M | May 12 | SEC ↗ |
Meister Keith A.First filing | Director, 10% Owner | Purchase | 171,389 | $7.0M | May 12 | SEC ↗ |
Meister Keith A.First filing | Director, 10% Owner | Purchase | 500,000 | $19.6M | May 12 | SEC ↗ |
| CHIEF EXECUTIVE OFFICER | Sale | 46,933 | $3.0M | Mar 30 | SEC ↗ | |
| CHIEF FINANCIAL OFFICER | Sale | 5,706 | $438K | Mar 17 | SEC ↗ | |
| CHIEF EXECUTIVE OFFICER | Sale | 17,179 | $1.3M | Mar 17 | SEC ↗ | |
| Chief Operating Officer | Sale | 5,961 | $511K | Feb 6 | SEC ↗ | |
Dechairo BryanFirst filing | Chief Operating Officer | Sale | 3,413 | $340K | Feb 3 | SEC ↗ |
| CHIEF EXECUTIVE OFFICER | Sale | 10,857 | $1.6M | Dec 18 | SEC ↗ | |
| CHIEF FINANCIAL OFFICER | Sale | 3,855 | $555K | Dec 18 | SEC ↗ | |
RUCH JOSHUAFirst filing | Insider | Sale | 38,000 | $6.1M | Nov 26 | SEC ↗ |
Feeley KevinFirst filing | CHIEF FINANCIAL OFFICER | Sale | 6,609 | $716K | Oct 1 | SEC ↗ |
Stueland KatherineFirst filing | CHIEF EXECUTIVE OFFICER | Sale | 12,858 | $1.4M | Oct 1 | SEC ↗ |
Related companies
GeneDx Holdings Corp. is in the Healthcare sector.